Clinical Trial Update: A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes. [Phase 3]

View source ↗

Summary

Phase 3 trial assessed the effectiveness and safety of Risperdal CONSTA added to standard treatment in bipolar disorder patients who have frequent mood episodes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED